Posted by Michael Wonder on 10 Jul 2019
Why disclosing drug prices in TV ads won't lower costs
10 July 2019 - A federal judge blocked President Donald Trump’s order to force drugmakers to disclose the list prices of medication in television ads. The ruling on Monday was a blow to the Trump administration’s efforts to pressure drugmakers to lower drug prices.
But it turns out what the Trump administration should consider doing is getting rid of drug TV ads in general, Tom Kottler, CEO of HealthPrize Technologies, told Yahoo Finance, adding that there’s only two countries that have drug ads — U.S. and New Zealand.
“The price people pay for their drugs is not the list price anyways,” Kottler told Yahoo Finance. “Putting out what they charge as a list price is actually more confusing than not. If you have a copay card for most of these drugs, you actually pay nothing, or maybe $20 a month... it's an incredibly confusing thing.”
